(Q24243203)

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment cha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Treatment of menorrhagia with meclofenamate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

The role of prostaglandins and allied substances in uterine haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

A preliminary study of factors influencing perception of menstrual blood loss volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Naproxen in menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Sources of variation in menstrual blood loss

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Studies in the involvement of prostaglandins in uterine symptomatology and pathology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Measurement of menstrual blood loss in patients complaining of menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

The treatment of premenstrual symptoms with mefenamic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000400.PUB2

7 January 2021

10.1002/14651858.CD000400.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_cjiy4267pfh5jkf5ijrq7d7ase

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cjiy4267pfh5jkf5ijrq7d7ase

24 November 2022